Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by Hankerchiefon Nov 29, 2018 3:36pm

84 Views

Post# 29041525

Who makes TLD 1433?

I thought I read in a previous post that Sigma Aldrich (Owned by Merck) makes TLD 1433. One would think that they would have some cash to throw TLT's way to help move this along seeing as they would be a big beneficiary from the production/sale of TLD 1433. I admit I don't know what I'm talking about but if I was going to supply a product for a company that had potential for growth like TLT, I might see what I could do to make it successful (if I had the means). For Merck to support TLD even if only to be able to sell a boatload of TLD 1433, seems reasonable. So is it true that Merck, which owns Sigma Aldrich, produces and supplies TLD 1433? Or am I bat chit crazy? Or both?

Bullboard Posts

Golden Minerals closes Yoquivo gold-silver project sale